Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 697

1.

Streptococcus pneumoniae: does antimicrobial resistance matter?

Lynch JP 3rd, Zhanel GG.

Semin Respir Crit Care Med. 2009 Apr;30(2):210-38. doi: 10.1055/s-0029-1202939. Epub 2009 Mar 18. Review.

PMID:
19296420
2.

Escalation of antimicrobial resistance among Streptococcus pneumoniae: implications for therapy.

Lynch JP 3rd, Zhanel GG.

Semin Respir Crit Care Med. 2005 Dec;26(6):575-616. Review.

PMID:
16388429
3.

Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines.

Lynch JP 3rd, Zhanel GG.

Curr Opin Pulm Med. 2010 May;16(3):217-25. doi: 10.1097/MCP.0b013e3283385653. Review.

PMID:
20375783
4.
5.

Penicillin-resistant pneumococci-implications for management of community-acquired pneumonia and meningitis.

Ziglam HM, Finch RG.

Int J Infect Dis. 2002 Mar;6 Suppl 1:S14-20. Review.

PMID:
12044285
6.

Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period.

LiƱares J, Ardanuy C, Pallares R, Fenoll A.

Clin Microbiol Infect. 2010 May;16(5):402-10. doi: 10.1111/j.1469-0691.2010.03182.x. Epub 2010 Feb 2. Review.

7.

Drug treatment of pneumococcal pneumonia in the elderly.

Neralla S, Meyer KC.

Drugs Aging. 2004;21(13):851-64. Review.

PMID:
15493950
8.

Drug-resistant pneumococcal pneumonia: clinical relevance and approach to management.

Fuller JD, McGeer A, Low DE.

Eur J Clin Microbiol Infect Dis. 2005 Dec;24(12):780-8. Review.

PMID:
16344922
9.

Clinical significance of pneumococcal resistance and factors influencing outcomes.

Bishai WR.

Treat Respir Med. 2005;4 Suppl 1:19-23. Review.

PMID:
15846153
10.

Streptococcus pneumoniae: epidemiology and patterns of resistance.

Jacobs MR.

Am J Med. 2004 Aug 2;117 Suppl 3A:3S-15S. Review.

PMID:
15360092
11.

The antimicrobial resistance profile of Streptococcus pneumoniae.

Reinert RR.

Clin Microbiol Infect. 2009 Apr;15 Suppl 3:7-11. doi: 10.1111/j.1469-0691.2009.02724.x. Review.

12.

Therapeutic options for pneumococcal pneumonia in Turkey.

Oncu S, Erdem H, Pahsa A.

Clin Ther. 2005 Jun;27(6):674-83. Review.

PMID:
16117975
13.

Worldwide trends in antimicrobial resistance among common respiratory tract pathogens in children.

Jacobs MR.

Pediatr Infect Dis J. 2003 Aug;22(8 Suppl):S109-19. Review.

PMID:
14566997
14.

Streptococcus pneumoniae as an agent of nosocomial infection: treatment in the era of penicillin-resistant strains.

Paradisi F, Corti G, Cinelli R.

Clin Microbiol Infect. 2001;7 Suppl 4:34-42. Review.

15.

Clinical relevance of penicillin-resistant Streptococcus pneumoniae.

Cunha BA.

Semin Respir Infect. 2002 Sep;17(3):204-14. Review.

PMID:
12226800
16.

Resistance among Streptococcus pneumoniae: Implications for drug selection.

Appelbaum PC.

Clin Infect Dis. 2002 Jun 15;34(12):1613-20. Epub 2002 May 16. Review.

PMID:
12032897
17.

[Pneumococcal antibiotic resistance].

Moreillon P, Wenger A, Caldelari I.

Rev Med Suisse Romande. 2000 Aug;120(8):651-9. Review. French.

PMID:
11028185
18.

Community-acquired pneumonia.

Cassiere HA, Niederman MS.

Dis Mon. 1998 Nov;44(11):613-75. Review.

PMID:
9858958
19.

Streptococcus pneumoniae in community-acquired pneumonia. How important is drug resistance?

Bauer T, Ewig S, Marcos MA, Schultze-Werninghaus G, Torres A.

Med Clin North Am. 2001 Nov;85(6):1367-79. Review.

PMID:
11680107
20.

Drug-resistant Streptococcus pneumoniae: rational antibiotic choices.

Jacobs MR.

Am J Med. 1999 May 3;106(5A):19S-25S; discussion 48S-52S. Review.

PMID:
10348060

Supplemental Content

Support Center